Glucomannan
Sponsors
Rush University Medical Center, Medical University of Warsaw, ProMedica Health System, Bambino Gesù Hospital and Research Institute, Northeast College of Health Sciences
Conditions
DysbiosisFunctional ConstipationFunctional Gastrointestinal DisordersHypoglycemiaInsulin ResistanceMetabolic SyndromeNon Alcoholic Fatty Liver DiseaseObesity
Phase 1
Phase 2
Phase 3
Phase 4
Effect of Daily Glucomannan in Overweight Patients
NCT01485718
Start: 2011-10-31End: 2012-03-31Target: 40Updated: 2011-12-13
Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood
CompletedNCT01495806
Start: 2010-01-31End: 2012-01-31Updated: 2025-07-22
Effect of Glucomannan Supplementation on Body Weight in Overweight and Obese Children
CompletedNCT02280772
Start: 2015-04-27End: 2018-03-28Updated: 2018-07-20
The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass Surgery
CompletedNCT02336438
Start: 2013-05-31End: 2014-11-30Updated: 2017-03-13